We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Dose Finding Study of HP802-247 in Venous Leg Ulcers
Updated: 2/15/2016
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Covered CP Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Updated: 2/15/2016
Covered Cheatham Platinum Stents for the Prevention or Treatment of Aortic Wall Injury Associated With Coarctation of the Aorta
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Buspirone as a Potential Treatment for Recurrent Central Apnea
Updated: 2/16/2016
Buspirone as a Potential Treatment for Recurrent Central Apneas
Status: Enrolling
Updated: 2/16/2016
Buspirone as a Potential Treatment for Recurrent Central Apnea
Updated: 2/16/2016
Buspirone as a Potential Treatment for Recurrent Central Apneas
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Updated: 2/16/2016
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials